A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Clinical trial NCT03691051 · UNKNOWN
Trial details
- NCT number
- NCT03691051
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2021-04-16
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.